Letter: Levamisole for warts. 1974

P Helin, and M Bergh

UI MeSH Term Description Entries
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D014860 Warts Benign epidermal proliferations or tumors; some are viral in origin. Verruca,Verrucas,Wart

Related Publications

P Helin, and M Bergh
February 1975, The New England journal of medicine,
P Helin, and M Bergh
September 1979, The British journal of dermatology,
P Helin, and M Bergh
April 1977, Archives of dermatology,
P Helin, and M Bergh
January 1980, Journal of the Indian Medical Association,
P Helin, and M Bergh
April 1975, Lancet (London, England),
P Helin, and M Bergh
March 1975, Lancet (London, England),
P Helin, and M Bergh
April 1975, Lancet (London, England),
P Helin, and M Bergh
February 1975, Lancet (London, England),
P Helin, and M Bergh
March 1975, Lancet (London, England),
P Helin, and M Bergh
March 1976, Lancet (London, England),
Copied contents to your clipboard!